Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.
Sign Up to like & getrecommendations! Published in 2017 at "Cytokine"
DOI: 10.1016/j.cyto.2016.11.011
Abstract: T helper 2 cells produce a number of cytokines including inteleukin (IL)-5, IL-4 and IL-13. Group 2 innate lymphoid cells (ILC2s) also produce IL-5 under sterile conditions. IL-5 is interdigitating homodimeric glycoprotein and a member… read more here.
Keywords: diseases bench; contribution discovery; allergic diseases; discovery interleukin ... See more keywords
Hericium erinaceus in Neurodegenerative Diseases: From Bench to Bedside and Beyond, How Far from the Shoreline?
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Fungi"
DOI: 10.3390/jof9050551
Abstract: A growing number of studies is focusing on the pharmacology and feasibility of bioactive compounds as a novel valuable approach to target a variety of human diseases related to neurological degeneration. Among the group of… read more here.
Keywords: hericium erinaceus; erinaceus; erinaceus neurodegenerative; diseases bench ... See more keywords
Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27144644
Abstract: Neurodegenerative diseases, such as Alzheimer′s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), currently represent major unmet medical needs. Therefore, novel therapeutic strategies are needed in order to improve patients’… read more here.
Keywords: inosine; bench bedside; inosine neurodegenerative; diseases bench ... See more keywords